PRIMARY STUDY
Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
Key Findings: The findings of this systematic review and meta-analysis support that palmitoylethanolamide (PEA) is a potential treatment for chronic pain. Studies found PEA to be overall effective and well-tolerated.
Type of Study: Clinical Meta-analysis
Study Sample Size: 11
Study Result: Positive
Research Location(s): Austria, Canada
Year of Pub: 2023
Cannabinoids Studied: Anandamide (AEA), Palmitoylethanolamide (PEA)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2, TRPV1, PPAR - Alpha
Citation: Lang-Illievich K, et al. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023; 15:(unknown pages). doi: 10.3390/nu15061350
Authors: Lang-Illievich K, Klivinyi C, Lasser C, Brenna CTA, Szilagyi IS, Bornemann-Cimenti H
